| P2093 | author name string | Shunya Uchida | |
| | Takanori Kumagai | |
| | Yoshihide Fujigaki | |
| | Shigeru Shibata | |
| | Tatsuru Ota | |
| | Yoshifuru Tamura | |
| | Zhong-yang Shen | |
| | Shigeyuki Arai | |
| | Wen-xiu Chang | |
| P2860 | cites work | Age affects outcomes in chronic kidney disease. | Q51107585 |
| | Short-term change in kidney function and risk of end-stage renal disease. | Q51327590 |
| | Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study | Q59575076 |
| | Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure | Q66938297 |
| | Serum electrolyte and acid base composition in patients with graded degrees of chronic renal failure | Q69973951 |
| | Effect of gender on the progression of nondiabetic renal disease: a meta-analysis | Q73426433 |
| | CKD Clinical Practice Guidebook. The essence of treatment for CKD patients | Q84193174 |
| | Evidence-based practice guideline for the treatment of CKD | Q84978295 |
| | Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population | Q85030658 |
| | Predicting progression of IgA nephropathy: new clinical progression risk score | Q31068314 |
| | Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients | Q33822935 |
| | Predicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study | Q33890631 |
| | Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission. | Q33906377 |
| | Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study | Q34990456 |
| | Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. | Q37625225 |
| | Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease | Q38018816 |
| | Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis | Q38138322 |
| | KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. | Q38197453 |
| | Preventing the progression of chronic kidney disease: two case reports and review of the literature. | Q38221804 |
| | Revised equations for estimated GFR from serum creatinine in Japan | Q39513402 |
| | KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update | Q39535980 |
| | Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects | Q43840677 |
| | The evolution of renal function and the incidence of end-stage renal disease in patients aged ≥ 50 years. | Q44585749 |
| | Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level | Q46867932 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 58-70 | |
| P577 | publication date | 2015-06-23 | |
| P1433 | published in | Clinical and experimental nephrology | Q26842022 |
| P1476 | title | Time-dependent risk factors associated with the decline of estimated GFR in CKD patients | |
| P478 | volume | 20 | |